Mallinckrodt has invested in 1 company and its latest investment was Silence Therapeutics on Jul 17, 2019
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
Silence Therapeutics is an England-based biotechnology company that develops RNA therapies for the treatment of cardiovascular, renal, metabolic and respiratory diseases.
